Cabozantinib Malate: Potent Multi-Target RTK Inhibitor for Cancer Research and Development
Explore the powerful anti-cancer properties of Cabozantinib Malate, a key player in modern oncology research.
Get a Quote & SampleProduct Core Value
Cabozantinib Malate
Cabozantinib Malate is a potent small molecule inhibitor targeting multiple receptor tyrosine kinases (RTKs). Its ability to inhibit VEGFR2, MET, RET, KIT, FLT3, and Tie2 makes it a valuable tool in cancer research, specifically for understanding and developing treatments that target tumor growth, angiogenesis, and metastasis.
- Discover the advantages of using a potent VEGFR inhibitor for your research needs.
- Learn how Cabozantinib Malate, a key RTK inhibitor, aids in cancer drug discovery.
- Explore the use of this high-purity pharmaceutical intermediate in developing novel oncology therapies.
- Investigate the significant impact of Cabozantinib Malate (CAS 1140909-48-3) in pre-clinical cancer models.
Key Advantages
Targeted Inhibition
Leverage Cabozantinib Malate's strong inhibition of VEGFR2 and other critical RTKs to advance your cancer research.
Tumor Growth & Metastasis Control
Utilize this RTK inhibitor to study mechanisms that impede tumor progression and reduce cancer metastasis.
High Purity & Quality
Ensure reliable research outcomes with a >99% purity white powder form of Cabozantinib Malate.
Key Applications
Oncology Drug Development
Cabozantinib Malate is a crucial API for developing novel cancer treatments, targeting pathways involved in tumor growth and survival.
Cancer Research Tools
As a potent small molecule RTK inhibitor, it serves as an indispensable tool for researchers investigating cancer biology.
Pharmaceutical Intermediates
This high-purity compound functions as a vital pharmaceutical intermediate in the synthesis of advanced anti-cancer agents.
Pre-clinical Studies
Explore the efficacy of Cabozantinib Malate in various pre-clinical models to understand its therapeutic potential.